Net Cash Provided by (Used in) Operating Activities |
-213K |
USD |
+48% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
131K |
USD |
+48.2% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
75M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
4.38M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-80.8K |
USD |
+75.1% |
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
17.4K |
USD |
-28.9% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Valuation Allowance |
253K |
USD |
+9.95% |
Q4 2024 |
FY 2024 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.25 |
pure |
0% |
Q2 2025 |
Q2 2025 |
Depreciation |
26.7K |
USD |
-0.72% |
Q2 2025 |
Q2 2025 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-310K |
USD |
-28.2% |
Q2 2025 |
Q2 2025 |
Property, Plant and Equipment, Gross |
141K |
USD |
+1.45% |
Q2 2025 |
Q2 2025 |
Current Income Tax Expense (Benefit) |
0 |
USD |
|
Q1 2025 |
Q1 2025 |
Additional Paid in Capital |
163K |
USD |
0% |
Q2 2025 |
Q2 2025 |
Depreciation, Depletion and Amortization |
6.61K |
USD |
-1.37% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
253K |
USD |
+9.95% |
Q4 2024 |
FY 2024 |